BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA.

MLA

Hirsch, Théo Z., et al. “BAP1 Mutations Define a Homogeneous Subgroup of Hepatocellular Carcinoma with Fibrolamellar-like Features and Activated PKA.” Journal of Hepatology, vol. 72, no. 5, May 2020, pp. 924–36. EBSCOhost, https://doi.org/10.1016/j.jhep.2019.12.006.

APA

Hirsch, T. Z., Negulescu, A., Gupta, B., Caruso, S., Noblet, B., Couchy, G., Bayard, Q., Meunier, L., Morcrette, G., Scoazec, J.-Y., Blanc, J.-F., Amaddeo, G., Nault, J.-C., Bioulac-Sage, P., Ziol, M., Beaufrère, A., Paradis, V., Calderaro, J., Imbeaud, S., & Zucman-Rossi, J. (2020). BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA. Journal of Hepatology, 72(5), 924–936. https://doi.org/10.1016/j.jhep.2019.12.006

Chicago

Hirsch, Théo Z., Ana Negulescu, Barkha Gupta, Stefano Caruso, Bénédicte Noblet, Gabrielle Couchy, Quentin Bayard, et al. 2020. “BAP1 Mutations Define a Homogeneous Subgroup of Hepatocellular Carcinoma with Fibrolamellar-like Features and Activated PKA.” Journal of Hepatology 72 (5): 924–36. doi:10.1016/j.jhep.2019.12.006.